Brief: Janux Therapeutics Q2 Basic EPS USD -0.11

Janux Therapeutics

07/08/2024 21:01

Aug 07 (Reuters) - Janux Therapeutics Q2 operating income USD -13.822 million.
* Q2 net income USD -5.959 million
* Q2 collaboration revenue USD 8.897 million
* Q2 operating expenses USD 22.719 million